Top Markets
Coin of the day
Pear Therapeutics, Inc. Pear Therapeutics, Inc.

Pear Therapeutics, Inc.

PEAR
Classifica tra le azioni #40500
Pear Therapeutics, Inc. is a commercial-phase medical company focused on... Pear Therapeutics, Inc. is a commercial-phase medical company focused on inventing and distributing digital therapeutics. Its current offerings include reSET, which addresses substance use disorders involving alcohol, cannabis, cocaine, and stimulants; reSET-O, prescribed alongside buprenorphine for opioid use disorder; and Somryst, a digital solution for chronic insomnia. Beyond these marketed therapies, the company maintains a robust development pipeline of 14 prospective products. These investigational treatments span various therapeutic areas, encompassing psychiatry, neurology, and non-central nervous system conditions like gastrointestinal, oncological, and cardiovascular disorders. Founded in 2013, Pear Therapeutics, Inc. is headquartered in Boston, Massachusetts.
Prezzo delle azioni
$0.0048
Ultima sincronizzazione: 2023-05-23
Capitalizzazione di mercato
$132.48K
Variazione (1 giorno)
-20.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Pear Therapeutics, Inc. (PEAR)

Categoria

Storico del prezzo dell'azione per Pear Therapeutics, Inc. (PEAR)
Prezzo di chiusura più alto: $0.01 il 2023-05-01

Prezzo di chiusura più basso: $6.62 il 2021-12-01
Storico del prezzo dell'azione di Pear Therapeutics, Inc. dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2023 -99.56%
2022 -75.88%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$73.79 -2.05%
US
$129.57 -33.40%
AU
$60.41 169.79%
US
$54.93 -21.11%
US
$30.49 0.00%
US